(2R,3R,4S,5S,6R)-2-[4-chloro-3-[(4-cyclopropylphenyl)methyl]indol-1-yl]-6-(1,2,4-oxadiazol-3-yl)oxane-3,4,5-triol | 1443338-94-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2R,3R,4S,5S,6R)-2-[4-chloro-3-[(4-cyclopropylphenyl)methyl]indol-1-yl]-6-(1,2,4-oxadiazol-3-yl)oxane-3,4,5-triol
• CAS: 1443338-94-0
• 化学式: C₂₅H₂₄ClN₃O₅
• 分子量: 481.936
• InChiKey: UFJIGJQIEHQGSN-LYVDORBWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  34
• 可旋转键数：
  5
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  114
• 氢给体数：
  3
• 氢受体数：
  7

文献信息

• NOVEL GLYCOSIDE COMPOUNDS
  申请人：National Health Research Institutes

  公开号：US20130157970A1

  公开（公告）日：2013-06-20

  Compounds of formula (I): wherein X, Y, and Z are defined herein. Also disclosed are pharmaceutical compositions and therapeutical methods related to these compounds.

  式（I）的化合物：其中X、Y和Z在此处定义。还披露了与这些化合物相关的药物组合物和治疗方法。
• [EN] NOVEL GLYCOSIDE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS GLYCOSIDES
  申请人：NAT HEALTH RESEARCH INSTITUTES

  公开号：WO2013090550A1

  公开（公告）日：2013-06-20

  Compounds of formula (I) as shown in the disclosure, in which X, Y, and Z are defined herein. Also disclosed are pharmaceutical compositions and therapeutical methods related to these compounds.